Introduction
Materials and methods
Research strategy
Study selection
Data extraction and methodological assessment
Statistical analysis
Results
Literature search and study characteristics
References | Ages (years) | Cases/controls | Follow-up period (years) | GH therapy period (years) | Recurrence/progress diagnosis | Intracranial tumor types | Study quality |
---|---|---|---|---|---|---|---|
Arslanian et al. [23], USA | NR (C) | 8/24 | 5.5 | NR | CT | Craniopharyngioma, germinoma, medulloblastoma, glioma, dermoid, retinoblastoma, metastatic rhabdomyosarcoma, chromophobe adenomas | 6 |
Clayton et al. [24], Norway | 10.8 ± 2.2 | 13/21 | NR | NR | NR | Medulloblastoma, glioma | 6 |
Ogilvy-Stuart et al. [25], UK | <14.4 | 47/160 | 5.1 | NR | NR | Medulloblastoma, glioma | 6 |
Swerdlow et al. [14], UK | <16 | 179/910 | 6.4a
4.5b
| NR | NR | Medulloblastoma, glioma, others | 8 |
Packer et al. [15], Canada | <15 | 545 | 5 | NR | NR | Medulloblastoma | 7 |
Sklar et al. [16], USA | <17.2 | 172/1489 | 6.2 | 4.6 | NR | Medulloblastoma, glioma | 8 |
Hatrick et al. [17], UK | NR | 47/28 | NR | 3.4 | CT MRI | Pituitary tumors, craniopharyngioma, meningioma | 7 |
Karavitaki et al. [18], UK | 17.6 ± 14.3a
38.8 ± 16.8b
| 32/53 | 10.8 ± 9.2a
8.3 ± 8.8b
| 6.3 ± 4.6 | CT MRI | Craniopharyngioma | 8 |
Buchfelder et al. [19], Germany | NR | 55/55 | 5 | 8.2 ± 6.7 | MRI | Pituitary adenomas | 8 |
Olsson et al. [20], Sweden | 49.6 ± 12.8a
51.6 ± 12.0b
| 121/114 | 9.9 ± 3.9 10.1 ± 4.4 | 10 ± 4 | CT MRI | Pituitary adenomas | 7 |
Arnold et al. [5], UK | 53.7 ± 14.6a
56.2 ± 14.0b
| 23/107 | 6.8 ± 4.2 | 4.6 ± 2.5 | CT MRI | Pituitary adenomas | 7 |
Rohrer et al. [21], Germany | <17.5 | 44/59 | 7.5a
4.5b
| NR | NR | Craniopharyngioma, medulloblastoma, ependymoma | 8 |
Mackenzie et al. [6], UK | 33a
29b
| 110/110 | 14.5a
15b
| 8a
NRb
| CT MRI | Pituitary adenomas, craniopharyngioma, intracranial neoplasm | 7 |
Olsson et al. [7], Sweden | 25.1 ± 16.4a
32.3 ± 16.9b
| 56/70 | 13.6 ± 5.0a
13.4 ± 7.8b
| 13.6 ± 5.0 | CT MRI | Craniopharyngioma | 7 |
Hartman et al. [22], USA | NR | 1309/339 | 2.3 ± 1.4a
2.3 ± 1.6b
| 0.5–1 | NR | Pituitary adenomas, craniopharyngioma. others | 6 |